Patent · US Active

Dried reconstituted vesicle formation for pharmaceutical application

US9526761B2 · kind B2 · utility

2Cited by

8References

7Claims

0Family size

Assignee

SCIL TECHNOLOGY GMBH · DE

Inventors

Klaus Hellerbrand · Moorenweis, DE
Andreas Schuetz · Martinsried, DE
Rainer Sigl · Puchheim, DE

Key dates

Filing date	Apr 6, 2009
Grant date	Dec 27, 2016
Priority date	—
Expiry date	Mar 18, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/19
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to dried reconstituted vesicle (DRV) compositions and water based formulations thereof, which contain one or more therapeutic agents (e.g. hydrophilic protein). More particularly, it relates to DRVs comprising at least one lipid and a fusion promoting agent which after reconstitution form large multilamellar liposomes encapsulating an active agent in an aqueous phase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.